title: Increased protein processing gene signature in HDACi-resistant cells predicts response to proteasome inhibitors.
authors.affiliation: a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
authors.forename: Daphné
authors.initials: D
authors.lastname: Dupéré-Richer
authors.affiliation: a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
authors.forename: Mena
authors.initials: M
authors.lastname: Kinal
authors.affiliation: a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
authors.forename: Filippa
authors.initials: F
authors.lastname: Pettersson
authors.affiliation: a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
authors.forename: Audrey
authors.initials: A
authors.lastname: Emond
authors.affiliation: b Division of Hematology and Oncology, Department of Medicine , Cornell University , New York , NY, USA.
authors.forename: M Nieves
authors.initials: MN
authors.lastname: Calvo-Vidal
authors.affiliation: a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
authors.forename: Jessica N
authors.initials: JN
authors.lastname: Nichol
authors.affiliation: a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
authors.forename: Cynthia
authors.initials: C
authors.lastname: Guilbert
authors.affiliation: a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
authors.forename: Dany
authors.initials: D
authors.lastname: Plourde
authors.affiliation: a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
authors.forename: Kathleen
authors.initials: K
authors.lastname: Klein Oros
authors.affiliation: a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
authors.forename: Torsten H
authors.initials: TH
authors.lastname: Nielsen
authors.affiliation: c Division of Hematology/Oncology , Robert. H. Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine , Chicago , IL, USA.
authors.forename: Teresa
authors.initials: T
authors.lastname: Ezponda
authors.affiliation: c Division of Hematology/Oncology , Robert. H. Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine , Chicago , IL, USA.
authors.forename: Jonathan D
authors.initials: JD
authors.lastname: Licht
authors.affiliation: a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
authors.forename: Nathalie A
authors.initials: NA
authors.lastname: Johnson
authors.affiliation: a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
authors.forename: Sarit
authors.initials: S
authors.lastname: Assouline
authors.affiliation: b Division of Hematology and Oncology, Department of Medicine , Cornell University , New York , NY, USA.
authors.forename: Leandro
authors.initials: L
authors.lastname: Cerchietti
authors.affiliation: a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
authors.forename: Wilson H
authors.initials: WH
authors.lastname: Miller
authors.affiliation: a Segal Cancer Center, Lady Davis Institute for Medical Research , McGill University , Montréal , QC , Canada.
authors.forename: Koren K
authors.initials: KK
authors.lastname: Mann
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D001896:Boron Compounds / Q000494:pharmacology; D000069286:Bortezomib / Q000494:pharmacology; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D020869:Gene Expression Profiling / Q000379:methods*; D005998:Glycine / Q000031:analogs & derivatives / Q000494:pharmacology; D056572:Histone Deacetylase Inhibitors / Q000494:pharmacology*; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism; D008297:Male; D016513:Mice, SCID; D011379:Prognosis; D061988:Proteasome Inhibitors / Q000494:pharmacology*; D020298:U937 Cells; D000077337:Vorinostat; D023041:Xenograft Model Antitumor Assays
chemical_list: D000970:Antineoplastic Agents; D001896:Boron Compounds; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; C000595706:MLN2238; D061988:Proteasome Inhibitors; D000077337:Vorinostat; D000069286:Bortezomib; D005998:Glycine